IGC Pharma, Inc. — Investor Relations & Filings
Filings indexed
762
across all filing types
Latest filing
2026-04-20
Regulatory Filings
Country
US
United States of America
Listing
US
IGC
IGC Pharma, Inc. is a clinical-stage biotechnology company focused on developing treatments for Alzheimer's disease. The company leverages artificial intelligence (AI) in its development process. Its lead candidate, IGC-AD1, is being evaluated in a Phase 2 clinical trial for treating agitation in patients with dementia due to Alzheimer's. The company's pipeline also includes TGR-63, a pre-clinical small molecule designed to inhibit amyloid plaque aggregation. Supporting its therapeutic development is MINT-AD, an AI-powered platform for the early detection of Alzheimer's and to improve the understanding of disease progression.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-04-20 | English | |
| 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-30 | English | |
| 10-KT - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-18 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-01-20 | English | |
| 8-K - IGC PHARMA, INC. (0001326205) (Filer) | 2026-01-06 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 34693717 | 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-04-20 | English | ||
| 33093350 | 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-30 | English | ||
| 32979091 | 10-KT - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-18 | English | ||
| 28898684 | 4 Filing | 2026-02-04 | English | ||
| 28898699 | 4 Filing | 2026-01-20 | English | ||
| 32890161 | 8-K - IGC PHARMA, INC. (0001326205) (Filer) | 2026-01-06 | English | ||
| 11848719 | FORM 8-K | 2026-01-02 | English | ||
|
2025
8 filings
| |||||
| 11848724 | FORM 8-K | 2025-12-15 | English | ||
| 11848723 | Regulatory Filings 2025 | 2025-12-08 | English | ||
| 11848725 | FORM S-3/A | 2025-12-03 | English | ||
| 11848731 | FORM S-3 | 2025-11-14 | English | ||
| 11848732 | FORM S-8 | 2025-11-14 | English | ||
| 11848730 | FORM 10-Q | 2025-11-14 | English | ||
| 11848726 | FORM 8-K | 2025-11-14 | English | ||
| 11848727 | Director's Dealing 2025 | 2025-10-22 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
HALOZYME THERAPEUTICS, INC.
Biopharmaceutical firm licensing technology to convert IV d…
|
HALO | US | Professional, scientific and te… |
|
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
Provides integrated R&D and manufacturing services for chem…
|
301096 | CN | Professional, scientific and te… |
|
Hangzhou Tigermed Consulting Co., Ltd.
Leading global Contract Research Organization (CRO) for ful…
|
3347 | HK | Professional, scientific and te… |
|
Hangzhou Tigermed Consulting Co.,Ltd.
Provides clinical research solutions for pharmaceutical, bi…
|
300347 | CN | Professional, scientific and te… |
|
HEALIOS K.K.
Clinical-stage biotech developing regenerative medicine and…
|
4593 | JP | Professional, scientific and te… |
|
HeartSciences Inc.
Medical technology company applying AI to electrocardiograp…
|
HSCS | US | Professional, scientific and te… |
|
Heartseed Inc.
Clinical-stage biotech developing regenerative medicine for…
|
219A | JP | Professional, scientific and te… |
|
Hemostemix Inc.
Clinical-stage biotech developing autologous stem cell ther…
|
HEM | CA | Professional, scientific and te… |
|
Herantis Pharma Oyj
A clinical-stage biotech developing therapies for neurodege…
|
HRTIS | FI | Professional, scientific and te… |
|
HEXIMA LIMITED.
Develops plant-derived proteins for human therapeutics and …
|
HXL | AU | Professional, scientific and te… |
IGC Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34705/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34705 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34705 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34705 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34705}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IGC Pharma, Inc. (id: 34705)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.